Skip to main content
. 2022 Oct 12;13:944452. doi: 10.3389/fimmu.2022.944452

Figure 1.

Figure 1

Current landscape for interventional immunotherapy clinical trials for GBM. Using clinicaltrials.gov/, condition or disease “glioblastoma”, type “interventional studies” and start study “01/01/2005” accessed on 03/20/2022.